Regulation 15 Amendment of the Pharmaceutical Regulations
(1)
Regulation 16 (claims and overpayments) is amended in accordance with paragraphs (2) to (4).
(2)
In paragraph (2) omit “, except to the extent that the Department, on the application of the Board, directs otherwise,”.
(3)
For “the Board” or “the Regional Board” in each place where it occurs, substitute “the Department”.
(4)
In paragraph (2)(b) for “the Department” substitute “the FPSIAP”.